Issue 19, 2009

A gorge-spanning, high-affinity cholinesterase inhibitor to explore β-amyloid plaques

Abstract

Cholinesterases are involved in the pathological formation of β-amyloid plaques. To investigate this pathohistological hallmark of Alzheimer's disease we prepared a high-affinity, fluorescent cholinesterase inhibitor. Its fluorescence intensity was significantly enhanced upon binding to cholinesterases. Using this probe, brain samples from mice and humans affected by Alzheimer's disease were successfully analyzed for β-amyloid plaques. Unexpectedly, it was discovered, by competition experiments, that the compound binds to amyloid structures, rather than to cholinesterases inside of the plaques.

Graphical abstract: A gorge-spanning, high-affinity cholinesterase inhibitor to explore β-amyloid plaques

Supplementary files

Article information

Article type
Paper
Submitted
14 May 2009
Accepted
16 Jun 2009
First published
17 Jul 2009

Org. Biomol. Chem., 2009,7, 3940-3946

A gorge-spanning, high-affinity cholinesterase inhibitor to explore β-amyloid plaques

P. W. Elsinghorst, W. Härtig, S. Goldhammer, J. Grosche and M. Gütschow, Org. Biomol. Chem., 2009, 7, 3940 DOI: 10.1039/B909612D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements